Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06477016 · ClinicalTrials.gov registry record
OsciPulse D-dimer Pilot Trial
A clinical trial of Ischemic Stroke, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 40
- Enrollment target
- 1
- Study location
NCT06477016: Recruiting study of Ischemic Stroke, sponsored by University of Pennsylvania.
NCT06477016 is a study of Ischemic Stroke that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 40 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06477016, a study of Ischemic Stroke, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
Pilot, randomized, non-blinded clinical trial to generate preliminary data to evaluate the impact of the OsciPulse system on serum d-dimer levels compared to standard of care intermittent compression therapy for DVT prophylaxis in patients admitted in the neuro ICU or intermediate neurological care unit with acute ischemic stroke.
Primary Outcome
Relative change in serum d-dimer levels for each subject from baseline to Day 7 or discharge
Conditions Studied
Interventions
- DEVICE OsciPulse
- DEVICE Intermittent Pneumatic Compression
Study Locations (1)
Pennsylvania
- HUP Neurology Dept. of Stroke and Neurocritical Care- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-02-12 |
| Est. Completion | 2026-02 |
What NCT06477016 shows while recruiting
NCT06477016 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which OsciPulse is the first listed.
NCT06477016 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06477016 about?
NCT06477016 is a clinical study titled "OsciPulse D-dimer Pilot Trial". Pilot, randomized, non-blinded clinical trial to generate preliminary data to evaluate the impact of the OsciPulse system on serum d-dimer levels compared to standard of care intermittent compression therapy for DVT prophylaxis in patients admitted in the neuro ICU or intermediate neurological care ...
What is the current status of trial NCT06477016?
This trial is currently recruiting. The enrollment target is 40 participants. The study started on 2025-02-12. Estimated completion is 2026-02.
What conditions does trial NCT06477016 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT06477016?
The interventions under investigation include: OsciPulse (DEVICE), Intermittent Pneumatic Compression (DEVICE).
Who is sponsoring clinical trial NCT06477016?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06477016 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06477016's enrollment target sits among peer trials
40 49th of 66 higher than 18 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Transitions of Care for Stroke Patients
RECRUITING
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI